A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine
Clinical trial NCT04967742 · COMPLETED
Trial details
- NCT number
- NCT04967742
- Sponsor
- United Biomedical Inc., Asia
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-05
- Primary completion
- 2021-08-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.